These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9801899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dapsone hypersensitivity syndrome among leprosy patients in China.
    Tian W, Shen J, Zhou M, Yan L, Zhang G.
    Lepr Rev; 2012 Dec; 83(4):370-7. PubMed ID: 23614255
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dapsone syndrome in Goa.
    Rege VL, Shukla P, Mascarenhas MF.
    Indian J Lepr; 1994 Dec; 66(1):59-64. PubMed ID: 7983393
    [Abstract] [Full Text] [Related]

  • 5. Dapsone hypersensitivity syndrome: a clinico-epidemiological review.
    Agrawal S, Agarwalla A.
    J Dermatol; 2005 Nov; 32(11):883-9. PubMed ID: 16361748
    [Abstract] [Full Text] [Related]

  • 6. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S, Nair NG.
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [Abstract] [Full Text] [Related]

  • 7. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S, Rege VL, Sehgal VN.
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [Abstract] [Full Text] [Related]

  • 8. Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
    Itha S, Kumar A, Dhingra S, Choudhuri G.
    BMC Gastroenterol; 2003 Aug 11; 3():21. PubMed ID: 12911838
    [Abstract] [Full Text] [Related]

  • 9. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR, Shrestha K, Pandey B, Walker SL.
    Lepr Rev; 2008 Dec 11; 79(4):425-8. PubMed ID: 19274989
    [Abstract] [Full Text] [Related]

  • 10. Dapsone hypersensitivity syndrome with myocarditis.
    Pereira CM, Vaz M, Kotha S, Santosh NH.
    J Assoc Physicians India; 2014 Aug 11; 62(8):728-31. PubMed ID: 25856947
    [Abstract] [Full Text] [Related]

  • 11. Dapsone dependent nodular panniculitis.
    Uplekar MW, Antia NH.
    Indian J Lepr; 1986 Aug 11; 58(2):286-90. PubMed ID: 3805799
    [Abstract] [Full Text] [Related]

  • 12. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
    Sheen YS, Chu CY, Wang SH, Tsai TF.
    J Dermatolog Treat; 2009 Aug 11; 20(6):340-3. PubMed ID: 19954390
    [Abstract] [Full Text] [Related]

  • 13. Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
    Balakrishnan S, Karthikeyan S, Ramu G.
    Indian J Lepr; 1989 Jan 11; 61(1):10-6. PubMed ID: 2703739
    [Abstract] [Full Text] [Related]

  • 14. Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome.
    Zhu KJ, He FT, Jin N, Lou JX, Cheng H.
    J Clin Pharm Ther; 2009 Aug 11; 34(4):489-92. PubMed ID: 19583683
    [Abstract] [Full Text] [Related]

  • 15. A lethal case of the dapsone hypersensitivity syndrome involving the myocardium.
    Hoogeveen RM, van der Bom T, de Boer HH, Thurlings RM, Wind BS, de Vries HJ, van Lent AU, Beuers U, van der Wal AC, Nellen FJ.
    Neth J Med; 2016 Feb 11; 74(2):89-92. PubMed ID: 26951355
    [Abstract] [Full Text] [Related]

  • 16. A study of 922 bacteriologically positive leprosy cases.
    Koticha KK, Nair PR, Juwatkar PS.
    Int J Lepr Other Mycobact Dis; 1982 Sep 11; 50(3):330-4. PubMed ID: 6890538
    [Abstract] [Full Text] [Related]

  • 17. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
    Sritharan V, Bharadwaj VP, Venkatesan K, Girdhar BK.
    Int J Lepr Other Mycobact Dis; 1981 Sep 11; 49(3):307-10. PubMed ID: 7198620
    [Abstract] [Full Text] [Related]

  • 18. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A, Balakrishnan S.
    Lepr India; 1982 Oct 11; 54(4):664-70. PubMed ID: 7183832
    [Abstract] [Full Text] [Related]

  • 19. Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.
    Chun JS, Yun SJ, Kim SJ, Lee SC, Won YH, Lee JB.
    Clin Exp Dermatol; 2009 Dec 11; 34(8):e798-801. PubMed ID: 19778310
    [Abstract] [Full Text] [Related]

  • 20. Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal.
    Rao PN, Lakshmi TS.
    Lepr Rev; 2001 Mar 11; 72(1):57-62. PubMed ID: 11355519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.